...
首页> 外文期刊>Journal of medical Internet research >Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences
【24h】

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

机译:转移黑色素瘤中免疫疗法期间的患者报告的结果:患者和临床医生经验的混合方法研究

获取原文

摘要

Background The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting of side effects and the derived communication. Objective The primary objective of this study was to examine patients’ and clinicians’ experiences with an eHealth intervention for weekly monitoring of side effects during treatment with immunotherapy. Methods An eHealth intervention based on questions from the PRO-Common Terminology Criteria for Adverse Events (CTCAE) library was used and tested in a randomized clinical trial with patients receiving immunotherapy for malignant melanoma and clinicians at a university hospital in Denmark. On a weekly basis, patients reported their symptoms from home during the treatment via a provided tablet. The electronic patient reports were available to clinicians in the outpatient clinic. A mixed methods approach was applied to investigate the patients’ and clinicians’ experiences with the intervention. Data from patient experiences were collected in a short survey, the Patient Feedback Form. Moreover, a subset of the patients participating in the survey was interviewed about their experience. Furthermore, one focus group interview with clinicians was carried out to elucidate their views. Results A total of 57 patients completed the Patient Feedback Form, and 14 patients were interviewed. The focus group interview included 5 clinicians. Overall, patients and clinicians were satisfied with the tool. They believed it enhanced patients’ awareness of side effects and increased their feeling of involvement. The patients reported that it was easy to fill out the questionnaire and that it made sense to do so. However, a minority of the patients expressed in the interviews that they did not believe that the health care professionals had seen their reports when they came to the clinic, and that the reporting did not lead to increased contact with the department. Conclusions Overall, satisfaction with the eHealth intervention was high among patients and their treating clinicians. The tool was easy to use and contributed to greater symptom awareness and patient involvement. Thus, in terms of patient and clinician satisfaction with the tool, it makes sense to continue using the tool beyond the project period. Trial Registration ClinicalTrials.gov NCT03073031; https://tinyurl.com/tjx3gtu
机译:背景技术电子患者报告的结果(Pro)调查问卷已经在许多环境中进行了证明,包括在医院和患者家中。然而,仍有待研究黑素瘤患者的患者和治疗临床医生如何体验副作用和衍生通信的电子报告。目的本研究的主要目标是审查患者的患者和临床医生对母羊干预治疗免疫疗法治疗期间对副作用的每周监测。方法采用基于普通术语(CTCAE)文库的问题的eHealth干预,并在随机临床试验中与丹麦大学医院接受恶性黑素瘤和临床医生接受免疫疗法的随机临床试验中。每周一次,患者通过提供的平板电脑在治疗过程中向家庭报告其症状。在门诊诊所的临床医生中可获得电子患者报告。混合方法采用方法来调查患者和临床医生在干预方面的经验。患者经验的数据在短暂的调查中收集,患者反馈表。此外,参加调查的患者的子集接受了他们的经验。此外,对临床医生进行了一个焦点小组访谈,以阐明他们的观点。结果共有57名患者完成患者反馈表,并采访了14名患者。焦点集团面试包括5名临床医生。总体而言,患者和临床医生对工具感到满意。他们认为它增强了患者对副作用的认识,增加了他们的参与感。患者报告说,很容易填写调查问卷,这样做是有意义的。然而,少数患者在采访中表达,他们并不相信医疗保健专业人员在他们来到诊所时已经看到了他们的报告,并且报告不会导致与该部门的联系增加。结论总体而言,对患者的母体干预的满意度高,患者治疗临床医生高。该工具易于使用,有助于提高症状意识和患者参与。因此,就患者和临床医生与工具的满意度来说,继续使用超出项目期间的工具是有意义的。试验登记ClinicalTrials.gov NCT03073031; https://tinyurl.com/tjx3gtu.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号